matiim

From insight to impact: competitive intelligence that drives action

Offerings & Capabilities

Matiim offers real-time competitive intelligence to help you anticipate market shifts, decode competitor strategies, and make confident decisions. Our services span both strategic and tactical support—from pipeline tracking and clinical benchmarking to launch preparedness and threat assessments. With ethically sourced human intelligence and deep domain expertise, we deliver insights that go beyond public data, drawing from expert networks, KOLs, and key stakeholders across global markets. Our intelligence is not only comprehensive but also contextualized—aligning closely with your brand priorities, therapeutic focus, and regional needs to drive impactful actions.

We Deliver Actionable Insights Across Diverse Functions in Pharma and Life Science Industry

At Matiim, we deliver decision-grade competitive intelligence rooted in firsthand insights — direct from the source, always validated, and never recycled. We help our clients navigate complex, competitive landscapes with clarity and confiden.

In strategy, CI supports portfolio prioritization, asset selection, and go-to-market planning by clarifying competitive dynamics and uncovering unmet needs. In decision-making, CI ensures leadership operates with clarity, reducing uncertainty and enabling faster, evidence-backed choices.

Competitive Intelligence (CI) clarifies market dynamics and unmet needs, enabling smarter portfolio choices, asset selection, and go-to-market planning. By turning fragmented insights into actionable foresight, CI reduces uncertainty and drives faster, evidence-based decisions.

See our insights for strategy / decision makers

Market Landscape – Analyze market share, adoption drivers, and disease dynamics shaping demand.

Treatment & Product Fit – Assess treatment sequences, positioning, and product-market alignment.

Competitor & Client Insights – Evaluate competitors’ client base, capabilities, earnings, and financials.

Technology & Commercial Strategies – Review sales channels, marketing plans, and tech differentiation.

CRO & Partner Capabilities – Map CRO expertise, revenue models, projects, and partnerships.

Pipeline & Lifecycle Strategy – Track competitor pipelines, lifecycle plans, and indication expansions.

Focus & Differentiation – Identify strategic priorities, focus areas, regions, and success stories.

Strengths, Weaknesses & Models – Benchmark market prioritization, revenue streams, and sales models.

Services & Solutions – Compare competitor offerings that strengthen positioning and complement portfolios

Early R&D leaders face pressure to stand out amid platform innovation and target crowding.

Competitive intelligence here guides both asset selection and portfolio strategy—mapping new modalities, assessing emerging targets, and spotting early translational signals. The result: smarter discovery bets with stronger downstream potential.

See our insights for drug discovery / research

MoA Insights – Compare mechanisms of action, highlighting key challenges and opportunities.

Biomarker-Driven Trial Design – Apply biomarker strategies to refine patient selection and improve outcomes.

Pipeline Tracking – Monitor early-stage assets and emerging MoAs in preclinical and clinical phases.

New Molecule Evaluation – Analyze scientific value and competitive edge of first- or best-in-class drugs.

Perception & Differentiation – Assess market and stakeholder insights to guide early product positioning.

Dosing & Formulation – Evaluate competitor strategies for dose, formulation, and delivery optimization

Preclinical development demands speed, safety, and rigor.

Competitive intelligence on tox programs, differentiation, and translational approaches reduces risk, clarifies readiness, and guides go/no-go decisions—critical in crowded and first-in-class spaces.

See our insights for preclinical development

PK/PD & Bioequivalence Analysis – Linking pharmacokinetics and pharmacodynamics with enrolment rationale and study adjustments.

Preclinical Manufacturing Readiness – Assessing scalability, formulation stability, and process development before clinical transition.

Toxicology Outsourcing Trends – Growing reliance on external partners for preclinical safety and tox studies.

Differentiation in Multi-Specific Biologics – Strategies to demonstrate unique value in increasingly crowded preclinical pipelines.

Bench-to-Bedside Pathways – Translational journeys of assets from academia and start-ups into development-ready programs.

Trial design now goes beyond endpoints—spanning sequencing, biomarkers, line strategy, and speed.

Competitive intelligence on peer positioning, protocol shifts, and novel designs (platform, adaptive) gives teams an edge to differentiate, de-risk timelines, and navigate complex landscapes in oncology and rare diseases.

See our insights for R&D / clinical development

Trial Design & Innovation – Define study arms, endpoints, biomarkers, safety, and novel trial models.

Competitive Landscape & Pipeline – Track ADCs, HER2-low, T-cell engagers, radioligands, and oncology platforms.

Operational Execution & Timelines – Monitor enrollment, site activation, delays, speed, and key readout schedules.

Patient Recruitment & Engagement – Assess recruitment strategies, subgroup analyses, RWE integration, and patient/physician drivers.

Global Development & Partnerships – Map regional expansion, trial site choices, and global development collaborations.

KOL & Investigator Insights – Evaluate investigator networks, KOL influence, and competitive trial perceptions.

Commercial & Label Strategy – Align trial design with positioning, label expansion, and differentiation goals.

Technology in Development – Apply AI, AR/VR, and digital tools to accelerate trial design and execution.

Regulatory success hinges on timing and precedent as much as science.

By analyzing filings, advisory trends, and feedback on emerging modalities, companies can craft smarter strategies for breakthroughs, platforms, and first-in-class assets. Global and regional intelligence aligns regulatory moves with access and launch planning.

See our insights for regulatory affairs

Filing & Approval Timelines – Track NDA, ANDA, IND, BLA, and OTC submissions, speed, and competitor moves.

Labeling & Indication Strategy – Assess multi-indication filings, label needs, and lifecycle extension options.

Global Regulatory Pathways – Navigate regional frameworks for biologics, RNA, and oncology, aligned with FDA precedents.

Submission Data & Evidence – Define filing requirements across clinical, safety, and real-world evidence.

Market Access & Reimbursement – Integrate payer expectations, reimbursement planning, and supportive data generation.

Regulatory Environment & Policy – Monitor tariffs, shifting regulations, and evolving approval routes.

Patent & Exclusivity Planning – Align patent expirations and exclusivity timelines with launch strategi

As modalities grow more complex, CMC now drives both timelines and investor confidence.

Competitive intelligence on CDMO capabilities, modular manufacturing, and regulatory expectations strengthens planning, while benchmarking supply chains, linker-payload platforms, and vendor maturity helps anticipate bottlenecks and align capabilities for future needs.

See our insights for CMC / chemistry / manufacturing

Facility & Process Innovation – Map facilities, optimize formulations, enable modular and smart manufacturing.

CDMO & Capability Benchmarking – Compare ADC linker-payload, fill-finish, packaging, and CDMO capabilities.

Production Capacity & Operations – Assess plant capacity, scale-up readiness, inspections, and operational bottlenecks.

Regulatory & Policy Environment – Track regulations, labeling rules, policy shifts, and compliance risks.

Supply Chain & Logistics – Monitor storage, shipments, logistics barriers, supply restrictions, and stock levels.

Raw Material & Procurement – Analyze supplier strength, material access, procurement hurdles, and cost trends.

Risk & Alternative Strategies – Build contingencies, backup routes, and mitigation plans for disruptions.

Medical Affairs is shifting from support to strategic influence.

Competitive intelligence on KOL engagement, digital exchange, and evidence planning informs stronger strategies—prioritizing engagement, sharpening messaging, and aligning internal goals with external narratives.

See our insights for medical affairs

MSL & Field Engagement – Scientific exchange, KOL engagement, and insight generation to shape strategy.

Medical Strategy & Messaging – Development of clear, resonant medical narratives aligned with therapeutic positioning.

Medical Affairs Programs – Grants, speaker initiatives, workshops, scientific sessions, and launch-driven medical activities.

Launch & Event Execution – Planning and leadership of medical launch events, content development, and frequency of scientific engagements.

Patient & Community Support – Education, awareness campaigns, advocacy partnerships, free product programs, and public service initiatives.

With access increasingly data-driven and value-focused, commercial strategy must begin earlier and move faster.

Competitive intelligence shapes pricing, reimbursement, launch sequencing, value story, and footprint expansion—while peer insights in crowded indications redefine go-to-market success.

See our insights for marketing / sales / commercial / market access

Commercial Strategy – Pricing, reimbursement, positioning, launch sequencing, and competitive benchmarking (e.g., TROP2 ADCs, radiopharmaceuticals, rare diseases).

Business Development & Partnerships – BD&L trends in immuno-oncology and cell therapy, co-promotion models, outsourcing, and sales partnerships.

Market & Regional Insights – Comparative analysis of footprints in APAC and other oncology markets; regional revenue, adoption, and access trends.

Go-to-Market Execution – Launch planning, timelines, messaging, team responsibilities, region prioritization, and share-of-voice benchmarking.

Sales Force Strategy – Team size, ramp-up, allocations, training, global breakdown, hiring priorities, and performance targets.

Promotional & Adoption Tactics –Sales channels, promotional partners, contracting models, co-pay and reimbursement support, discounts, free samples, and patient assistance.

Customer & Stakeholder Engagement – HCP and patient targeting, KOL selection, value-story articulation, and experience feedback loops.

Lifecycle planning is dynamic, with rivals driving label expansions, RWE strategies, and combinations deep into maturity.

Competitive intelligence here ensures sustained differentiation, strategic evidence generation, and defense against late-stage entrants—critical to maximizing commercial value and extending relevance beyond launch.

See our insights for post marketing / life cycle management

Label Expansion Tracking – Monitoring new indication approvals across oncology and specialty therapies.

Lifecycle Extension Strategies – Tactics to sustain value in mature franchises (e.g., immuno-oncology) through ongoing development.

Therapy-Specific Expansion Trends – For e.g., Analysis of label growth in HER2-targeted treatments and checkpoint inhibitors (anti-PD1/PD-L1).

Geographic Performance Insights – Regional variations in uptake, expansion success, and lifecycle outcomes.

Our Capabilities Across Diverse Industries

Competitor profiling & benchmarking

Deep-dive profiles of key competitors
Product portfolio and pipeline comparisons
Strategy benchmarking (R&D, marketing, BD)
SWOT and competitive positioning

Market entry & go-to-market intelligence

Entry strategy analysis for new geographies
Competitor entry / exit tracking
Go-to-market models and channel strategy evaluation
Localization and regulatory landscape insights

M&A and licensing intelligence

Target screening and partner identification
Deal benchmarking and prior art review
Technology/asset fit and competitive landscape
Due diligence support with CI insights

Early signal detection & horizon scanning

Monitoring Clinical trial progress, data readout, presentation
regulatory filings, patents,

Strategic forecasting & scenario planning

Market forecasting and opportunity assessment
War gaming and simulation exercises
Early signal detection and trend spotting
What-if scenario planning (e.g., competitor launch, price drop)

Pricing, market access & reimbursement intelligence

Deep-dive profiles of key competitors
Product portfolio and pipeline comparisons
Strategy benchmarking (R&D, marketing, BD)
SWOT and competitive positioning

Sales & marketing intelligence

Salesforce structure and incentive strategy
Marketing campaigns, messaging and positioning
Channel/distribution strategy tracking
Digital footprint and omnichannel analysis

Primary intelligence gathering

In-depth interviews with customers, KOLs, ex-employees
Competitive field force shadowing (ethically sourced)

Technology scouting & IP tracking

Emerging technology mapping and scouting
Platform / tech fit with market trends
Identifying the solutions for R&D challenges and uncovering innovations that can revolutionize current product lines through proactive processes
Assisting in brand extensions and product development
Patent filings and innovation signals
Disruptive startups and VC investment watch

Scientific & R&D intelligence

Clinical trial benchmarking
Publication and congress surveillance
R&D investment tracking
investigator networks and scientific influence
Scientific Literature tracking and benchmarking

Product & competitive landscaping

Identify target organizations with appropriate technical matches and interest in collaboration
Perform relationship management and negotiation support for licensing and partnership agreements
Product landscapes & benchmarking
Competitive landscaping & benchmarking
Pipeline product landscaping
Intelligence on competitor’s R&D strategy, product pipeline, technology roadmap and product life-cycle management objectives

Technology intelligence

Get a macro and micro level understanding of a given technology space
Analyze a range of technologies to understand the best fit for their needs
Get intelligence on the technologies that competitors are focusing on or investing on
Analyze relative strengths of competitors on a variety of business and technology parameters
Technology application scouting
Technology availability and value proposition assessment

Industry & ecosystem mapping